Real-world persistence and costs among patients with chronic migraine treated with onabotulinumtoxinA or calcitonin gene-related peptide monoclonal antibodies
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Real-world persistence and costs among patients with chronic migraine treated with onabotulinumtoxinA or calcitonin gene-related peptide monoclonal antibodies
Authors
Keywords
-
Journal
Journal of Managed Care & Specialty Pharmacy
Volume 29, Issue 10, Pages 1119-1128
Publisher
Academy of Managed Care Pharmacy
Online
2023-09-30
DOI
10.18553/jmcp.2023.29.10.1119
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A real-world study of acute and preventive medication use, adherence, and persistence in patients prescribed fremanezumab in the United States
- (2022) Lynda J. Krasenbaum et al. JOURNAL OF HEADACHE AND PAIN
- International Classification of Headache Disorders - ICHD-4 alpha
- (2020) Peter J Goadsby et al. CEPHALALGIA
- Failure of preventive treatments in migraine: an observational retrospective study in a tertiary headache center
- (2020) Marianna Delussi et al. BMC Neurology
- CGRP ligand and receptor monoclonal antibodies for migraine prevention: Evidence review and clinical implications
- (2019) David W Dodick CEPHALALGIA
- ARISE: A Phase 3 randomized trial of erenumab for episodic migraine
- (2018) David W Dodick et al. CEPHALALGIA
- Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States
- (2018) Machaon Bonafede et al. HEADACHE
- The American Headache Society Position Statement On Integrating New Migraine Treatments Into Clinical Practice
- (2018) HEADACHE
- Galcanezumab in chronic migraine
- (2018) Holland C. Detke et al. NEUROLOGY
- Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
- (2017) Stewart Tepper et al. LANCET NEUROLOGY
- Fremanezumab for the Preventive Treatment of Chronic Migraine
- (2017) Stephen D. Silberstein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: A retrospective claims analysis
- (2016) Zsolt Hepp et al. CEPHALALGIA
- Direct and Indirect Costs of Chronic and Episodic Migraine in the United States: A Web-Based Survey
- (2016) Andrew Messali et al. HEADACHE
- The Prevalence and Burden of Migraine and Severe Headache in the United States: Updated Statistics From Government Health Surveillance Studies
- (2015) Rebecca C. Burch et al. HEADACHE
- Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS)
- (2012) L. M. Bloudek et al. JOURNAL OF HEADACHE AND PAIN
- Cost of Health Care Among Patients With Chronic and Episodic Migraine in Canada and the USA: Results From the International Burden of Migraine Study (IBMS)
- (2011) Michael Stokes et al. HEADACHE
- Global prevalence of chronic migraine: A systematic review
- (2009) JL Natoli et al. CEPHALALGIA
- The Burden of Migraine in the United States: Current and Emerging Perspectives on Disease Management and Economic Analysis
- (2008) Elisabeth Hazard et al. VALUE IN HEALTH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started